Skip to main content

International Journal of Hematology

Ausgabe 4/2021

Inhalt (18 Artikel)

Rapid Communication

A simple method to distinguish residual elotuzumab from monoclonal paraprotein in immunofixation assays for multiple myeloma patients

Shurui Chen, Toru Kiguchi, Yasuyuki Nagata, Yotaro Tamai, Takeshi Ikeda, Ryoko Kajiya, Takaaki Ono, Daisuke Sugiyama, Hiroyoshi Nishikawa, Yoshiki Akatsuka

Original Article

Validation of an analytical method for the quantification of human fibrinogen in pharmaceutical products by size-exclusion liquid chromatography (SEC-HPLC)

Rocío Hernández-Longoria, Yadira Hernández-Ruiz, Fany Gutiérrez-Jasso, Abraham Zarazúa

Original Article

Utilization of a novel Sendai virus vector in ex vivo gene therapy for hemophilia A

Yuni Yamaki, Takashi Fukushima, Naomi Yoshida, Ken Nishimura, Aya Fukuda, Koji Hisatake, Masayuki Aso, Tomoki Sakasai, Junko Kijima-Tanaka, Yoshihiro Miwa, Mahito Nakanishi, Ryo Sumazaki, Hidetoshi Takada

Original Article

Clinical impacts of the mutational spectrum in Japanese patients with primary myelofibrosis

Soji Morishita, Tomonori Ochiai, Kyohei Misawa, Satoshi Osaga, Tadaaki Inano, Yasutaka Fukuda, Yoko Edahiro, Akimichi Ohsaka, Marito Araki, Norio Komatsu

Original Article

Clostridium perfringens sepsis in three patients with acute leukemia and review of the literature

Fuhong Liu, Song Xue, Yongping Zhang, Jingxian Yang, Jiajun Hu, Di Li, Xiaojun Ma, Jingbo Wang

Original Article

Effect of donor type on volume of blood transfusions required after allogeneic hematopoietic cell transplantation

Saiko Kurosawa, Takuhiro Yamaguchi, Saori Nakabayashi, Moemi Kasane, Misato Tsubokura, Nao Iwashita, Yuki Minakawa, Ryuzaburo Ohtake, Kimihiko Kawamura, Yukiko Nishioka, Wataru Takeda, Tuneaki Hirakawa, Jun Aoki, Ayumu Ito, Takashi Tanaka, Yoshihiro Inamoto, Sung-Won Kim, Minoru Kojima, Minoko Takanashi, Takahiro Fukuda

Original Article

Comparative evaluation of reagents for measuring protein S activity: possibility of harmonization

Masahiro Ieko, Taeko Hotta, Kumiko Watanabe, Tomoko Adachi, Sawako Takeuchi, Sumiyoshi Naito, Mika Yoshida, Kazumasa Ohmura, Nobuhiko Takahashi, Eriko Morishita, Hiroko Tsuda, Dongchon Kang

Original Article

Glycosylated ferritin as an improved marker for post-transfusion iron overload

Ayako Ishihara, Tsuyuko Yamauchi, Katsuyoshi Ikeda, Yoko Fukuyoshi, Toshiro Yokoyama, Yuji Yonemura, Mitsuhiro Uchiba, Hirotaka Matsui

Original Article

The role of minimal residual disease in specific subtypes of pediatric acute lymphoblastic leukemia

Yu-juan Xue, Yu Wang, Yue-ping Jia, Ying-xi Zuo, Jun Wu, Ai-dong Lu, Le-ping Zhang

Original Article

Chronic graft-versus-host disease in children and adolescents with thalassemia after hematopoietic stem cell transplantation

Oranooj Lertkovit, Usanarat Anurathapan, Suradej Hongeng, Nintita Sripaiboonkit Thokanit, Samart Pakakasama

Original Article

Impact of cGVHD on socioeconomic outcomes in survivors with pediatric hematopoietic stem cell transplant in Japan: a cross-sectional observational study

Takafumi Soejima, Masaaki Shiohara, Yasushi Ishida, Masami Inoue, Akira Hayakawa, Atsushi Sato, Kiyoko Kamibeppu, Yoshiko Atsuta, Takuya Yamashita

Original Article

Screening for M-proteinemia consisting of monoclonal gammopathy of undetermined significance and multiple myeloma for 30 years among atomic bomb survivors in Hiroshima

Kingo Fujimura, Aya Sugiyama, Tomoyuki Akita, Masayuki Ohisa, Shintaro Nagashima, Keiko Katayama, Ryo Maeda, Junko Tanaka

Case Report

Monitoring of MYD88 L265P mutation by droplet digital polymerase chain reaction for prediction of early relapse in a patient with Bing–Neel syndrome

Hisaharu Shikata, Hisafumi Kihara, Masahiko Kaneko, Shoichi Matsukage, Keiichiro Hattori

Case Report

Pathological and molecular analysis of a composite lymphoma of mantle cell lymphoma and Epstein–Barr virus-positive follicular lymphoma

Yuri Miyazawa, Akihiko Yokohama, Takuma Ishizaki, Norifumi Tsukamoto, Hiromi Koshi, Junko Hirato, Hiroshi Handa

Case Report

A case of JAK2V617F-positive essential thrombocythemia where allele burden was reduced by a PD-1 inhibitor

Ryujiro Hara, Hiroshi Kawada, Yara Yukie Kikuti, Eri Kikkawa, Kaito Harada, Yasuyuki Aoyama, Daisuke Ogiya, Masako Toyosaki, Rikio Suzuki, Sinichiro Machida, Ken Ohmachi, Makoto Onizuka, Yoshiaki Ogawa, Ryota Masuda, Masayuki Iwazaki, Naoya Nakamura, Kiyoshi Ando

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.